← Leaderboards
Leanna J Standish
Bastyr University
$9,521,468
Attributed
$10,948,521
Total exposure
13
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2005–14$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$14,987,411 · 14
By mechanism
U19$9,095,373 · 6
R01$3,231,019 · 2
T32$1,405,295 · 1
R21$994,913 · 4
U01$260,811 · 1
Top collaborators
- Mary L. Disis6 shared
- Marin Robyn Andersen5 shared
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseImmune ResponseAlternative MedicinePreventStagingWomanImmunityAgaricalesPlacebosPolysaccharide-KSafetyMalignant Breast NeoplasmAgonistDoseJapanCancer PatientClinical TrialsOncologyTumorCenter For Translational Science ActivitiesComplementary And Alternative MedicineBiomarkerBaseDrug Kinetics
Grant awards (35)
Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study$481,558
R01 · FY2014 · AT · contact PI
Augmenting immunity via HER2-targeted immunotherapy and PSK M.Disis/L.Standish$686,787
U19 · FY2013 · AT · contact PI
Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study$597,510
R01 · FY2013 · AT · contact PI
Bastyr/UW Oncomycology Translational Research Center$300,784
U19 · FY2013 · AT · contact PI
Bastyr/UW Oncomycology Translational Research Center$1,207,565
U19 · FY2012 · AT · contact PI
Augmenting immunity via HER2-targeted immunotherapy and PSK M.Disis/L.Standish$827,215
U19 · FY2012 · AT · contact PI
Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study$612,433
R01 · FY2012 · AT · contact PI
Enhancing innate immunity by combining PSK with docetaxel in/C.Higano/C.Wenner$380,350
U19 · FY2012 · AT · contact PI
Enhancing innate immunity by combining PSK with docetaxel in/C.Higano/C.Wenner$142,000
U19 · FY2012 · AT · contact PI
Bastyr/UW Oncomycology Translational Research Center$142,000
U19 · FY2012 · AT · contact PI
Bastyr/UW Oncomycology Translational Research Center$1,106,200
U19 · FY2011 · AT · contact PI
Augmenting immunity via HER2-targeted immunotherapy and PSK M.Disis/L.Standish$897,391
U19 · FY2011 · AT · contact PI
Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study$568,938
R01 · FY2011 · AT · contact PI
Enhancing innate immunity by combining PSK with docetaxel in/C.Higano/C.Wenner$504,417
U19 · FY2011 · AT · contact PI
Training in Complementary and Alternative Medical Research$170,848
T32 · FY2011 · AT · contact PI
Bastyr/UW Oncomycology Translational Research Center$134,898
U19 · FY2011 · AT · contact PI
Bastyr/UW Oncomycology Translational Research Center$1,147,443
U19 · FY2010 · AT · contact PI
Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study$593,668
R01 · FY2010 · AT · contact PI
Augmenting immunity via HER2-targeted immunotherapy and PSK M.Disis/L.Standish$590,985
U19 · FY2010 · AT · contact PI
Enhancing innate immunity by combining PSK with docetaxel in/C.Higano/C.Wenner$556,458
U19 · FY2010 · AT · contact PI
Training in Complementary and Alternative Medical Research$352,546
T32 · FY2010 · AT · contact PI
Training in Complementary and Alternative Medical Research$581,092
T32 · FY2009 · AT · contact PI
Training in Complementary and Alternative Medical Research$300,809
T32 · FY2008 · AT · contact PI
Project 3 - Phase I/II Trial of Trametes Versicolor$154,867
U19 · FY2006 · AT · contact PI
Project 3 - Phase I/II Trial of Trametes Versicolor$149,604
U19 · FY2005 · AT
Project 3 - Phase I/II Trial of Trametes Versicolor$166,409
U19 · FY2004 · AT
North American Naturopathic Medical Research Consortium$172,492
R21 · FY2003 · AT
Ayurvedic Center for Collaborative Research$132,620
R21 · FY2003 · AT
North American Naturopathic Medical Research Consortium$172,494
R21 · FY2002 · AT
GARLIC THERAPY IN HYPERLIPIDEMIA CAUSED BY HAART$260,811
U01 · FY2001 · AT
TRANSFER OF NEURAL ENERGY BETWEEN HUMAN SUBJECTS$180,021
R21 · FY2001 · AT
METHODS IN COMPLEMENTARY/ALTERNATIVE MEDICINE &HIV/AIDS$1,260
R01 · FY2001 · AT
METHODS IN COMPLEMENTARY/ALTERNATIVE MEDICINE &HIV/AIDS$375,652
R01 · FY2000 · AT
TRANSFER OF NEURAL ENERGY BETWEEN HUMAN SUBJECTS$172,351
R21 · FY2000 · AT
GARLIC THERAPY IN HYPERLIPIDEMIA CAUSED BY HAART$164,935
R21 · FY2000 · AT